Immigran to extend its indication to menstrual migraine.

Yuyu has obtained the KFDA approval on Immigran for the treatment of menstrual associated migraine (MAM) in addition to the existing indication of "an early relief of migraine pain with or without prodromes". The MAM commonly occurs in women before and after the menstrual period.

The MAM patients, a most prevalent migraine, experience a migraine pain during the menstrual period more frequen...